Sarepta Therapeutics Inc. (SRPT) Stock: Jason Karp Is A Shareholder Again And Has A Larger Position Than Ever

Page 8 of 8

Page 8 of 8 – SEC Filing
EXHIBIT A
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock with $0.0001 par value, of Sarepta Therapeutics, Inc. dated October 28, 2016, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated:
October 28, 2016
TOURBILLON CAPITAL PARTNERS LP
By:  /s/ Brian A. Kessler
             Brian A. Kessler,
             Chief Financial Officer
/s/ Jason H. Karp
     Jason H. Karp

Follow Sarepta Therapeutics Inc. (NASDAQ:SRPT)

Page 8 of 8